Cambridge Investment Research Advisors, Inc. Dynavax Technologies Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 24,044 shares of DVAX stock, worth $260,156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,044Holding current value
$260,156% of portfolio
0.0%Shares
21 transactions
Others Institutions Holding DVAX
# of Institutions
290Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$237 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$193 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$99.1 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$84.3 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$71 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.37B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...